Gastroenterology

Gastroenterology

Volume 113, Issue 2, August 1997, Pages 606-614
Gastroenterology

The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome

https://doi.org/10.1053/gast.1997.v113.pm9247483Get rights and content

Abstract

BACKGROUND & AIMS: The hepatopulmonary syndrome occurs when intrapulmonary vasodilatation causes impaired arterial gas exchange in liver disease. The pathogenesis is poorly understood, although nitric oxide may be involved. Common bile duct ligation in the rat is a model of the hepatopulmonary syndrome, but no studies have evaluated NO in pulmonary vasodilatation in this model. The aim of this study was to determine whether NO contributes to intrapulmonary vasodilatation after bile duct ligation.

METHODS: Endothelial and inducible NO synthase (NOS) levels and localization and NO activity in pulmonary artery rings were assessed after bile duct ligation.

RESULTS: Pulmonary endothelial NOS levels increased and alveolar vascular staining was enhanced after bile duct ligation. No change in pulmonary inducible NOS levels or localization was detected. Increased endothelial NOS levels correlated with alterations in gas exchange and were accompanied by enhanced NO activity and a blunted response to phenylephrine, reversible by NOS inhibition, in pulmonary artery rings. Portal-vein-ligated animals, which do not develop intrapulmonary vasodilatation, had no changes in pulmonary NOS production or in NO activity in pulmonary artery rings.

CONCLUSIONS: NO, derived from pulmonary vascular endothelial NOS, contributes to intrapulmonary vasodilation in animal hepatopulmonary syndrome.

(Gastroenterology 1997 Aug;113(2):606-14)

References (0)

Cited by (214)

  • Hepatopulmonary syndrome

    2022, JHEP Reports
    Citation Excerpt :

    The underlying processes responsible for these 3 mechanisms are described in more detail below and are summarised in Fig. 3. Circulating endothelin-1 (ET-1) levels and hepatic production are increased in both human and experimental cirrhosis.21,22,24 ET-1 classically acts as a potent vasoconstrictor, including in the portal circulation where it increases sinusoidal and pre-sinusoidal resistance.

  • Hepatopulmonary Syndrome

    2021, Encyclopedia of Respiratory Medicine, Second Edition
  • Pulmonary Complications of Portal Hypertension

    2019, Clinics in Liver Disease
    Citation Excerpt :

    HPS has also been diagnosed in patients with presinusoidal portal hypertension with otherwise normal liver function. A rat common bile duct ligation model of HPS has immensely helped in the understanding of this syndrome.117,118 In this model, proliferating cholangiocytes in the liver produce and secrete ET-1.117,118

View all citing articles on Scopus
View full text